Characterization of the somatostatin receptor subtype in a bronchial carcinoid tumor responsible for Cushing's syndrome.
Small ACTH-secreting carcinoid tumors responsible for Cushing's syndrome are often difficult to localize using available radiological investigations. Somatostatin receptors have been found in about 90% of carcinoid tumors studied, leading to a new approach for the localization of tumors or metastasis by using radiolabeled somatostatin analogs. We report a case of Cushing's syndrome due to an ACTH-secreting bronchial carcinoid tumor, completely suppressible with octreotide treatment and evidenced by body scintigraphy with 111In-labeled pentreotide. After removal, which led to patient recovery, the tumor was studied in vitro. In situ hybridization, using a complementary DNA probe, revealed POMC messenger ribonucleic acid in a subpopulation of tumor cells. These cells were labeled by immunochemistry using an antiserum directed against ACTH. Confocal laser scanning microscopy analysis showed that the ACTH-immunoreactive peptide was sequestered in secretory granules. Autoradiographic labeling using [125I-Tyrzero,D-Trp8]somatostatin-14 demonstrated the presence of somatostatin-binding sites in the whole tumor tissue. The relative affinities of various selective somatostatin analogs and the ability of GTP to inhibit radioligand binding suggested that the receptor expressed in the tumor cells belonged to the SSTR-2 subtype.
Lefebvre
H
H
European Institute for Peptide Research, Groupe Hospitalo-Universitaire de Recherche en Hormonologie, Rouen, France.
Jégou
S
S
Leroux
P
P
Dero
M
M
Vaudry
H
H
Kuhn
J M
JM
D000328:Adult; D001345:Autoradiography; D001984:Bronchial Neoplasms / Q000150:complications* / Q000175:diagnosis / Q000378:metabolism; D002276:Carcinoid Tumor / Q000150:complications* / Q000175:diagnosis / Q000378:metabolism; D003480:Cushing Syndrome / Q000209:etiology*; D005455:Fluorescent Antibody Technique; D006801:Humans; D017403:In Situ Hybridization; D008297:Male; D008854:Microscopy, Electron; D011333:Pro-Opiomelanocortin / Q000378:metabolism; D017481:Receptors, Somatostatin / Q000145:classification* / Q000378:metabolism*; D014057:Tomography, X-Ray Computed
D017481:Receptors, Somatostatin; D011333:Pro-Opiomelanocortin